Internet-delivered pain self-management to reduce pain and interference in chronic pancreatitis
Active Project Grant Awarded Last action
- Award ID
- R01DK137520
- Recipient
-
Seattle Children's Hospital UEI SZ32VTCXM799
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,036,150
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date 64% complete
- Place of performance
- Seattle, WA 98101, USA
Award details come from USAspending.gov.
Description
- Abstract
- Severe abdominal pain is a cardinal symptom of pancreatitis, present in up to 90% of patients with recurrent acute pancreatitis (RAP) and chronic pancreatitis (CP). As pain increases in severity and constancy, IT is associated with significant morbidity including depression and anxiety symptoms, low physical functioning, sleep disturbance, and low quality of life, as well as high economic and societal burden. Painful RAP and CP is most often managed with chronic opioids, which unfortunately have limited efficacy and substantial risk for adverse side effects. This application focuses on addressing this treatment GAP in pain management with a well-established nonpharmacologic intervention. Our team has established efficacy of an internet-delivered cognitive-behavioral therapy (CBT) intervention for chronic pain, and recently adapted IT for pancreatitis pain (the pancreatitis pain course), showing promise for reducing pain and disability in this population. We propose a hybrid effectiveness-implementation design type 1 trial to make rapid translational gains with the primary goal of gathering data on CBT treatment effects on pancreatitis pain and pain interference in individuals with RAP and CP with a secondary goal of gathering implementation data to inform dissemination of the pancreatitis pain course to real-world settings. Our central hypothesis is that the pancreatitis pain course will be effective in reducing pain interference and severity in individuals with painful RAP and CP. Our specific aims are to 1) determine the effectiveness of the pancreatitis pain course in improving pancreatitis pain outcomes, 2) (exploratory) explore the moderating effects of social determinants of health with changes in pain interference and severity following treatment, and 3) identify implementation facilitators, challenges, and solutions for structures and processes that contribute to the seamless integration of the pancreatitis pain course into clinical centers and the community. This study will leverage resources of the chronic pancreatitis, diabetes, and pancreatic cancer (cpdpc) consortium, a niddk-sponsored U01 consortium with recruitment from their nine clinical centers and from self-referral in the community through partnership with the national pancreas foundation. Using a multicenter randomized-controlled pragmatic clinical trial, we will enroll 280 individuals with painful CP into the clinical trial and randomize them to CBT, providing access to the pancreatitis pain course to learn pain self-management skills (e.g., relaxation, activity pacing, goal setting) or education control (access to education website about RAP and CP pain). We will collect patient-reported outcomes at baseline, two months, and six-month follow-up. Relevant stakeholder groups (patients, providers, organizational managers) will participate in a process evaluation to inform future implementation in clinic and community settings. The proposed investigation will significantly advance solutions for nonopioid pain management in CP. If successful, our project will minimize disparities in care, and address a critical need for low-cost, accessible pain self-management for individuals with painful CP.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $697,377 | |
| Amendment | $706,679 | |
| Amendment | $726,463 | |
| Original award | $905,631 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| Baylor College Of Medicine | $56,794 | |
| Regents Of The University Of Minnesota | $62,197 | |
| Trustees Of Indiana University | $55,795 | |
| The Leland Stanford Junior University | $58,308 | |
| Cedars-Sinai Medical Center | $62,459 | |
| Macquarie University | $53,094 | |
| University Of Florida | $34,518 | |
| Mayo Clinic | $38,786 | |
| The Ohio State University | $59,040 | |
| The University Of Kentucky Research Foundation | $196,434 | |
| University Of Pittsburgh - Of The Commonwealth System Of Higher Education | $115,488 | |
| University Of Illinois | $127,060 |
Show all 12
Quick answers
Who received award R01DK137520?
R01DK137520 was awarded to Seattle Children's Hospital by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on September 1, 2023.
How much is award R01DK137520 worth?
$3,036,150 has been obligated on R01DK137520.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award